Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
The Active After Cancer Trial (AACT)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL
- Status
- TERMINATED
- Phase
- PHASE1
Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease
- Status
- COMPLETED
- Phase
- PHASE1
Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function
- Status
- COMPLETED
- Phase
- N/A
Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors
- Status
- COMPLETED
- Phase
- PHASE2
RAD001 in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Campath in Chronic GVHD
- Status
- COMPLETED
- Phase
- PHASE1
Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
- Status
- COMPLETED
- Phase
- N/A
Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response
- Status
- COMPLETED
- Phase
- PHASE2